Cargando…
Artemisinin and Its Derivate Alleviate Pulmonary Hypertension and Vasoconstriction in Rodent Models
BACKGROUND: Pulmonary arterial hypertension (PAH) is a complex pulmonary vasculature disease characterized by progressive obliteration of small pulmonary arteries and persistent increase in pulmonary vascular resistance, resulting in right heart failure and death if left untreated. Artemisinin (ARS)...
Autores principales: | Bao, Changlei, He, Qian, Wang, Hui, Sun, Yanan, Xu, Yahang, Pan, Yan, Hu, Yadan, Zheng, Shichuang, Liang, Shuxin, Luo, Ang, Nahar, Tanzilan, Chen, Jiwang, Tang, Haiyang, Han, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232380/ https://www.ncbi.nlm.nih.gov/pubmed/35757500 http://dx.doi.org/10.1155/2022/2782429 |
Ejemplares similares
-
Artemisinin Improves Acetylcholine-Induced Vasodilatation in Rats with Primary Hypertension
por: Liu, Xuanxuan, et al.
Publicado: (2021) -
Hypoxia-Inducible Factor 2-Alpha Mediated Gene Sets Differentiate Pulmonary Arterial Hypertension
por: Zhu, Jinsheng, et al.
Publicado: (2021) -
AMPK and Pulmonary Hypertension: Crossroads Between Vasoconstriction and Vascular Remodeling
por: Zhao, Qiang, et al.
Publicado: (2021) -
Hypoxic Pulmonary Vasoconstriction and the Diffusing Capacity in Pulmonary Hypertension Secondary to Idiopathic Pulmonary Fibrosis
por: Sakao, Seiichiro, et al.
Publicado: (2019) -
Optimization of isolated perfused/ventilated mouse lung to study hypoxic pulmonary vasoconstriction
por: Yoo, Hae Young, et al.
Publicado: (2013)